Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone.
NCT ID: NCT05534334
Last Updated: 2022-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
30 participants
INTERVENTIONAL
2022-05-01
2022-11-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Diode Laser and Sclerotherapy in Treatment of Oral Pyogenic Granuloma
NCT05099081
Alternating Triamcinolone and Platelet-Rich Plasma Therapy for Oral Submucous Fibrosis
NCT07277998
Application of Hyaluronic Acid in Diabetes
NCT05543434
The Use of Adhesion Molecule Loaded Hydrogel With Minimally Invasive Surgical Technique in Treatment of Periodontal Intrabony Defect
NCT05653245
Effect of Laser and Sclerotic Agent in the Treatment of Oral Granuloma
NCT06639230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a particularly valuable approach for patients who have PG in the esthetic zone allowing the surgeon to keep maximum amount of periodontal tissues.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control arm
Surgical excision of the gingival pyogenic granuloma
Solu-Cortef
A vial sol. used for intra-mascular injection
Intervention
Intralesional injection with corticosteroids solution (1.8 mL of 100 mg hydrocortisone)
Solu-Cortef
A vial sol. used for intra-mascular injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Solu-Cortef
A vial sol. used for intra-mascular injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beni-Suef University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eman Magdy Ahmed
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eman Magdy, PhD
Role: PRINCIPAL_INVESTIGATOR
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beni_Suef University
Banī Suwayf, Beni Suweif Governorate, Egypt
Eman Ahmed
Banī Suwayf, Benisuef, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17/4/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.